Satellos Bioscience (MSCLF)
OTHER OTC:MSCLF
Holding MSCLF?
Track your performance easily

Satellos Bioscience (MSCLF) Financial Statements

18 Followers

Satellos Bioscience Financial Overview

Satellos Bioscience's market cap is currently ―. The company's EPS TTM is $-0.15; its P/E ratio is -4.22; Satellos Bioscience is scheduled to report earnings on November 20, 2024, and the estimated EPS forecast is $-0.04. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBITC$ -6.91MC$ -6.53MC$ -3.52KC$ -4.00MC$ -1.66M
EBITDAC$ -6.91MC$ -6.53MC$ -5.83KC$ -4.00MC$ -1.66M
Net Income Common StockholdersC$ -6.91MC$ -6.53MC$ -3.57KC$ -4.11MC$ -1.67M
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsC$ 33.17MC$ 39.59MC$ 44.26KC$ 48.73MC$ 2.98M
Total AssetsC$ 38.26MC$ 44.30MC$ 48.68KC$ 53.07MC$ 7.05M
Total DebtC$ 0.00C$ 0.00C$ 0.00C$ 2.08MC$ 2.03M
Net DebtC$ -33.17MC$ -39.59MC$ -44.26KC$ -46.65MC$ -957.26K
Total LiabilitiesC$ 3.75MC$ 3.62MC$ 2.32KC$ 3.88MC$ 4.92M
Stockholders EquityC$ 34.50MC$ 40.67MC$ 46.36KC$ 49.19MC$ 2.13M
Cash Flow-
Free Cash FlowC$ -7.13MC$ -14.51M-C$ -3.89MC$ -1.18M
Operating Cash FlowC$ -7.13MC$ -14.49MC$ 5.06MC$ -3.88MC$ -1.18M
Investing Cash FlowC$ -2.10MC$ -17.54MC$ 6.85KC$ -6.87K-
Financing Cash Flow-C$ 50.98MC$ -53.00MC$ 50.81MC$ 2.24M
Currency in CAD

Satellos Bioscience Earnings and Revenue History

Satellos Bioscience Debt to Assets

Satellos Bioscience Cash Flow

Satellos Bioscience Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis